Risk Factors for Disease Progression in Patients with Lower Urinary Tract Symptoms/benign Prostatic Hyperplasia (LUTS/BPH): a Systematic Analysis of Expert Opinion
Overview
Authors
Affiliations
Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.
Ahmed M, Prasannakumary R, Ravichandran A, Nazir A, Gnanavelu H, Pascal S Cureus. 2024; 16(10):e72223.
PMID: 39583458 PMC: 11584171. DOI: 10.7759/cureus.72223.
Gacci M, Makrides P, Spatafora P Prostate Cancer Prostatic Dis. 2023; 27(2):170-171.
PMID: 38040844 DOI: 10.1038/s41391-023-00761-4.
Molero J, Minana B, Palacios-Moreno J, Martinez-Fornes M, Lorite Mingot D, Agra Rolan A Int J Clin Pract. 2020; 74(11):e13602.
PMID: 32609933 PMC: 7685138. DOI: 10.1111/ijcp.13602.
Yi Q, Gong M, Chen C, Hu W, Zhu R BMC Urol. 2019; 19(1):82.
PMID: 31481034 PMC: 6724326. DOI: 10.1186/s12894-019-0513-1.
Jo J, Kim K, Nam J, Choi B, Moon H Int Neurourol J. 2017; 21(2):143-151.
PMID: 28673065 PMC: 5497199. DOI: 10.5213/inj.1732760.380.